163 related articles for article (PubMed ID: 26778713)
1. Comparison of Renal Cell Carcinoma Surveillance Guidelines: Competing Trade-Offs.
Lobo JM; Nelson M; Nandanan N; Krupski TL
J Urol; 2016 Jun; 195(6):1664-70. PubMed ID: 26778713
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the National Comprehensive Cancer Network and American Urological Association renal cell carcinoma surveillance guidelines.
Stewart SB; Thompson RH; Psutka SP; Cheville JC; Lohse CM; Boorjian SA; Leibovich BC
J Clin Oncol; 2014 Dec; 32(36):4059-65. PubMed ID: 25403213
[TBL] [Abstract][Full Text] [Related]
3. Post partial nephrectomy surveillance imaging: an evidence-based approach.
Marconi L; Gorin MA; Allaf ME
Curr Urol Rep; 2015 Apr; 16(4):23. PubMed ID: 25749808
[TBL] [Abstract][Full Text] [Related]
4. Surveillance Following Nephron-Sparing Surgery: An Assessment of Recurrence Patterns and Surveillance Costs.
Zargar-Shoshtari K; Kim T; Simon R; Lin HY; Yue B; Sharma P; Spiess PE; Poch MA; Pow Sang J; Sexton WJ
Urology; 2015 Aug; 86(2):321-6. PubMed ID: 26187013
[TBL] [Abstract][Full Text] [Related]
5. The Usefulness of Chest X-Rays for T1a Renal Cell Carcinoma Surveillance.
Canvasser NE; Stouder K; Lay AH; Gahan JC; Lotan Y; Margulis V; Raj GV; Sagalowsky AI; Cadeddu JA
J Urol; 2016 Aug; 196(2):321-6. PubMed ID: 26880407
[TBL] [Abstract][Full Text] [Related]
6. Guideline of guidelines: follow-up after nephrectomy for renal cell carcinoma.
Williamson TJ; Pearson JR; Ischia J; Bolton DM; Lawrentschuk N
BJU Int; 2016 Apr; 117(4):555-62. PubMed ID: 26617405
[TBL] [Abstract][Full Text] [Related]
7. Follow-up after curative treatment of localised renal cell carcinoma.
Dabestani S; Marconi L; Kuusk T; Bex A
World J Urol; 2018 Dec; 36(12):1953-1959. PubMed ID: 29767327
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Guidelines on Non-Muscle Invasive Bladder Cancer (EAU, CUA, AUA, NCCN, NICE).
Power NE; Izawa J
Bladder Cancer; 2016 Jan; 2(1):27-36. PubMed ID: 27376122
[TBL] [Abstract][Full Text] [Related]
9. Nurse-led renal cell carcinoma clinic: a single center review.
Thia I; Tan A; Botha E; Picardo A; Brown M; Thyer I; Abdul-Hamid A; Tan A; Teichmann D; Hayne D; McCombie SP
ANZ J Surg; 2024 Jun; 94(6):1071-1075. PubMed ID: 38426382
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the cost of CA-125 measurement, physical exam, and imaging in the diagnosis of recurrent ovarian cancer.
Armstrong A; Otvos B; Singh S; Debernardo R
Gynecol Oncol; 2013 Dec; 131(3):503-7. PubMed ID: 24060416
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic radiation exposure during surveillance in patients with pT1a renal cell carcinoma.
Lipsky MJ; Shapiro EY; Hruby GW; McKiernan JM
Urology; 2013 Jun; 81(6):1190-5. PubMed ID: 23540857
[TBL] [Abstract][Full Text] [Related]
12. Optimal Surveillance Strategies After Surgery for Renal Cell Carcinoma.
Tyson MD; Chang SS
J Natl Compr Canc Netw; 2017 Jun; 15(6):835-840. PubMed ID: 28596262
[TBL] [Abstract][Full Text] [Related]
13. Development of a nomogram predicting metastatic disease and the assessment of NCCN, AUA and EAU guideline recommendations for bone imaging in prostate cancer patients.
Ma MW; Gao XS; Lyu F; Gu XB; Yin H; Li HZ; Li XY; Qi X; Bai Y; Chen JY
World J Urol; 2021 Jun; 39(6):1815-1823. PubMed ID: 32691147
[TBL] [Abstract][Full Text] [Related]
14. Axial Abdominal Imaging after Partial Nephrectomy for T1 Renal Cell Carcinoma Surveillance.
Sorokin I; Canvasser NE; Margulis V; Lotan Y; Raj G; Sagalowsky A; Gahan JC; Cadeddu JA
J Urol; 2017 Nov; 198(5):1021-1026. PubMed ID: 28442383
[TBL] [Abstract][Full Text] [Related]
15. [When is aftercare useful in renal cell cancer?].
Ebert T; Fischer C
Urologe A; 2005 Sep; 44(9):1018, 1020-3. PubMed ID: 16047197
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the Harms, Advantages, and Costs Associated With Alternative Guidelines for the Evaluation of Hematuria.
Georgieva MV; Wheeler SB; Erim D; Smith-Bindman R; Loo R; Ng C; Garg T; Raynor M; Nielsen ME
JAMA Intern Med; 2019 Oct; 179(10):1352-1362. PubMed ID: 31355874
[TBL] [Abstract][Full Text] [Related]
17. Significant variability in 10-year cumulative radiation exposure incurred on different surveillance regimens after surgery for pT1 renal cancers: yet another reason to standardize protocols?
Lin YK; Gettle L; Raman JD
BJU Int; 2013 May; 111(6):891-6. PubMed ID: 23331317
[TBL] [Abstract][Full Text] [Related]
18. The current management of renal cell carcinoma.
Kuusk T; Grivas N; de Bruijn R; Bex A
Minerva Med; 2017 Aug; 108(4):357-369. PubMed ID: 28176516
[TBL] [Abstract][Full Text] [Related]
19. Local Tumor Bed Recurrence Following Partial Nephrectomy in Patients with Small Renal Masses.
Wood EL; Adibi M; Qiao W; Brandt J; Zhang M; Tamboli P; Matin SF; Wood CG; Karam JA
J Urol; 2018 Feb; 199(2):393-400. PubMed ID: 28941919
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of the risk of radiation exposure and cost of reduced imaging intensity for surveillance of early-stage nonseminomatous germ cell tumors.
Su D; Faiena I; Tokarz R; Bramwit M; Weiss RE
Urology; 2015 Jan; 85(1):141-6. PubMed ID: 25530376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
